Wannan shafin yana aiwatar da ayyuka na asali kuma bai shirya don amfanin marasa lafiya ba tukuna.
Wannan shafin yana aiwatar da ayyuka na asali kuma bai shirya don amfanin marasa lafiya ba tukuna.
Don bayani kawai — ba shawarar likita ba ne
Yaya tsananinsa?
Haɗarin mutuwa
Eh
Allurar rigakafi tana nan?
Lokacin zuwa alamomi
Ƙasashen da abin ya shafa
Annobar da ke gudana
Ka tabbatar da allurar karfafawa ta Tdap na yanzu (kowace shekara 10). Pertussis yana yaduwa a duniya baki daya kuma barkewar cuta tana faruwa a dukkan kasashe. Yana da muhimmanci musamman idan kana tafiya tare da ko ziyartar jarirai. "Tarin kwanaki 100" na iya shafar tsare-tsaren tafiya sosai.
Tari mai tsanwa (pertussis/whooping cough) cuta ce mai tsananin yaduwa da ƙwayar Bordetella pertussis ke haifarwa. Tana da haɗari musamman ga jarirai.
Highly contagious respiratory disease characterized by severe coughing fits.
Tarin kafada (Pertussis/Whooping Cough) cutar kwayoyin cuta ce da Bordetella pertussis ke haddasa ta. Adadin yaduwa a cikin gida: kashi 80–90%. Mafi hadari ga jarirai 'yan watanni <6 (kashi 90% na mutuwa). Cutar tana dawo wa a duniya tun shekarar 2010. Ana ba da shawarar rigakafin mata masu ciki da Tdap (a kowane daukar ciki) don kare jariri. A Najeriya, allurar DPT/Pentavalent tana cikin jadawalin NPHCDA.
Tsayawar numfashi/shuɗewar jiki (cyanosis) a jariri. Farfadiya. Rashin iya cin abinci. Zazzabi >38.5°C tare da tari (ciwon huhu na iya kasancewa).
Alamomi da alamu mafi yawa
Matakin mura (catarrhal, mako 1–2): kamar mura na yau da kullum — ba a iya bambancewa. Matakin tari na kafada (paroxysmal, mako 2–8): jerin tari + sautin shaƙar iska mai tsawa (whoop) + amai bayan tari. Tsayawar numfashi a jarirai (ba tare da sautin whoop ba). Matakin warwarewa (convalescent, mako 2–6). Ana kiran cutar "tari na kwanaki dari" (100-day cough) saboda tsawon lokacin.
Sanin alamomi shine mataki na farko don amsa cikin sauri.
Matakan cutar pertussis:
Alamomi marasa al'ada: Manya da yara da aka yi musu allurar rigakafi galibi suna da tari mai tsawo ba tare da murɗa na gargajiya ba. Jarirai ƙasa da watanni 3 na iya nuna tsayawar numfashi maimakon tari.
Yadda ake gano wannan cutar
Culture daga nasopharyngeal swab (gold standard amma sensitivity ya yi kasa). PCR — ya fi dacewa. Gwajin antibodies (serology). A Najeriya, rashin isasshen gwaje-gwaje yana sa kamuwa da cutar ba a sanar da shi sosai.
Hanyoyin magani da ake da su
Azithromycin kwanaki 5 (maganin farko, amintacce ga jarirai). Clarithromycin kwanaki 7. A kwantar da duk jarirai 'yan watanni <6 a asibiti. Sa ido na kowane lokaci (apnea monitoring). Maganin rigakafi ga duk wanda ya yi mu'amala da mai cuta a gida.
Yawancin lokuta ana magance su yadda ya kamata tare da gano cutar da wuri.
Yadda za ka kare kanka
DPT/Pentavalent a yara (jadawalin NPHCDA: makonni 6, 10, 14). Tdap ga mata masu ciki a kowane daukar ciki (makonni 20–36) — ba a aiwatar da hakan sosai a Najeriya har yanzu. Dabarar "cocoon" (rigakafin iyaye da masu kula da jariri).
Shirye-shirye shine mafi kyawun kariya.
A tabbatar an yi allura. Mata masu ciki masu shirin tafiya: a yi Tdap idan ba a yi ba tukuna. Hatsari ga jarirai a cikin jirgin sama da wuraren cunkoson jama'a.
Ƙididdiga da bayanan yanki
A Najeriya, ba a sanar da yawan shari'o'in pertussis sosai saboda wahalar gwajin cutar. A duniya, WHO ta kiyasta mutuwar jarirai 160,000+ a shekara. Cutar tana dawo wa ko a kasashen da suka ci gaban rigakafi saboda raguwar kariya bayan shekaru.
Wanene ke cikin haɗarin mafi girma
Risk factors for pertussis infection and severe outcomes are primarily related to age, vaccination status, and proximity to infectious contacts.
Risk factors for infection:
Waning immunity: Pertussis immunity is not lifelong, whether acquired through vaccination or natural infection. Acellular vaccine protection wanes after 4–6 years; whole-cell vaccine protection after 4–15 years; natural immunity after 7–20 years. This creates large pools of susceptible adolescents and adults who drive ongoing transmission.
Household exposure: Secondary attack rates among susceptible household contacts are 80–90% — among the highest of any infectious disease. The primary source of infant infection is usually a household member (parent, sibling, or grandparent) with unrecognized pertussis.
Incomplete vaccination: Children who have not completed the primary series (3 doses) have substantially higher risk. Even a partial series provides some protection, but full protection requires ≥3 doses.
Crowded settings: Schools, daycare centers, military barracks, dormitories — pertussis outbreaks are frequently school-based.
Epidemic cycles: Pertussis epidemics occur every 3–5 years even in countries with >90% DTP3 coverage, reflecting the accumulation of susceptible individuals as vaccine immunity wanes.
Risk factors for severe disease and death:
Age <6 months: The highest-risk group for severe pertussis, hospitalization, and death. Infants this age have not yet completed the primary vaccine series and may lack protective maternal antibodies (especially if the mother was not vaccinated with Tdap during pregnancy). Apnea, pneumonia, pulmonary hypertension, and encephalopathy are disproportionately common.
Prematurity and low birth weight: Increased risk of severe pertussis due to smaller airways, immature immune function, and lower transplacental antibody transfer.
Absence of maternal Tdap vaccination: Infants born to unvaccinated mothers have 3–5× higher risk of pertussis in the first 2 months of life.
Comorbid respiratory disease: Asthma, bronchopulmonary dysplasia, and other chronic lung conditions may exacerbate the severity and duration of pertussis.
Extreme leukocytosis: WBC >100,000/µL in infants is an independent predictor of mortality, associated with leukostasis, pulmonary hypertension, and refractory hypoxemia.
Risk factors for prolonged cough in adults:
Asthma and chronic respiratory conditions
Active smoking
Advanced age
Immunocompromised status
Rikitarwa da za ta iya faruwa
Ciwon huhu (pneumonia) — babban sanadin mutuwa a jarirai. Tsayawar numfashi (apnea). Farfadiya. Kumburin kwakwalwa (encephalopathy) daga rashin isasshen oxygen. Pneumothorax daga tsananin tari. Mutuwa: mafi yawa a jarirai 'yan watanni <2.
Sakamakon da ake tsammani da murmurewa
Jarirai ƙasa da watanni 6: Mafi girman haɗari da mutuwa. CFR 1–3% a cikin jariran da ba a yi musu allurar rigakafi ba. Babban dalilin mutuwar pertussis.
Yara manya da manya: Ba kasafai ya kashe ba amma yana haifar da tsawon rashin lafiya. "Tari na kwanaki 100."
Matsaloli:
Ciwon huhu (babban dalilin mutuwa a jarirai): 5–10%.
Tashin farfaɗo: 1–2%, yawanci na zazzaɓi.
Cutar ƙwaƙwalwa: 0.1–0.3%.
Karya haƙarƙari, fitila, zubar da jini a ido (daga tarin da ya yi tsanani).
Ƙaiƙayin tari bayan pertussis na iya ci gaba na watanni.
Rigakafi: Kamuwa ta halitta na ba da kariya na shekaru 7–20. Rigakafin da allurar ta ba da yana raguwa cikin shekaru 5–10.
Ana iya hana wannan cuta ta hanyar allurar rigakafi. Kariya mai inganci tana samuwa.
Yi magana da ƙwararren lafiyar tafiya game da jadawalin da aka ba da shawarar kafin tafiyar ku.
Nemo asibitin allurar rigakafi →Kun san allurar rigakafin da kuke bukata? Da kyau. Ba ku sani ba? Ku gaya mana inda kuke tafiya — za mu nemo allurar da ta dace da asibiti. Kyauta, ba tare da wani hakki ba.
Abun ciki a wannan shafin don bayani da ilimi ne kawai. Ba ya zama shawarar likita, gano cuta, ko shawarwarin magani ba. Idan kuna da damuwar lafiya, tuntuɓi ƙwararren ma’aikacin lafiya. SafeTripVax ba mai ba da sabis na likitanci ba ne.
Cikakkun sharuɗɗan amfaniRecent epidemiological data from the World Health Organization Global Health Observatory.
Source: WHO GHO OData ↗
And 15 more records
This data is provided for informational purposes. Please consult official WHO sources for the most current information.
View WHO data source →